Over the last three years we have had a significant government-funded vaccine development program. Some of the resulting products have been sold to local vaccine companies and may be available for sub-licensing; some are in the final stages of development.

• Actinobacillus pleuropneumonia (APP) bacterin
• Actinobacillus pleuropneumonia (APP) subunit vaccine
• Mycoplasma hyopneumoniae subunit vaccine
• Mycoplasma hyorhinis subunit vaccine
• Mycoplasma hyopneumoniae / Mycoplasma hyorhinis bivalent bacterin
• Mycoplasma hyopneumoniae / Porcine circovirus type 2 (PCV2) bivalent subunit vaccine
• Porcine circovirus type 2 (PCV2) subunit vaccine
• Porcine epidemic diarrhea virus (PEDV) subunit vaccine
• Porcine reproductive and respiratory syndrome virus (PRRSV) subunit vaccine
• Salmonella cholerasuis attenuated vaccine

Products for Mycoplasma hyopneumoniae vaccines on the market

Several vaccines are currently at proof of concept stage.

• Mycoplasma gallisepticum bacterin
• Mycoplasma gallisepticum subunit vaccine
• Mycoplasma synoviae bacterin
• Mycoplasma synoviae subunit vaccine